Soluble expression of recombinant human CD137 ligand in Escherichia coli by co-expression of chaperones. 2012

Shuzhen Wang, and Aimin Tan, and Junfang Lv, and Peng Wang, and Xiaojin Yin, and Yijun Chen
Laboratory of Chemical Biology, China Pharmaceutical University, Nanjing, China.

CD137 ligand (CD137L) is a member of the tumor-necrosis factor superfamily that binds CD137 to provide positive co-stimulatory signals for T cells activation. Co-stimulation through CD137/CD137L has become one of the promising approaches for cancer therapy. Previous reports have shown that CD137L expressed in Escherichia coli resulted in inclusion bodies or low yield. In this study, the effects of five different chaperone teams on the soluble expression of recombinant human CD137L protein were explored and analyzed. The poor expression of CD137L in the cytoplasm of E. coli was improved significantly by co-expression of chaperone GroES-GroEL-Tf. After dual induction and affinity chromatography, purified recombinant CD137L was obtained at a yield of 3 mg protein per liter with purity greater than 98% from original undetectable level. Additionally, the purified recombinant CD137L could bind CD137-positive cells in a dose-dependent manner, markedly promote the growth of activated mice T cells, and elevate the release of IL-2. The present work provides an effective system for soluble expression of functional human co-stimulatory molecule CD137L, which will facilitate the clinical developments of recombinant protein drugs.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005285 Fermentation Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID. Fermentations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001709 Biotechnology Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level (i.e., GENETIC ENGINEERING) is a central focus; laboratory methods used include TRANSFECTION and CLONING technologies, sequence and structure analysis algorithms, computer databases, and gene and protein structure function analysis and prediction. Biotechnologies

Related Publications

Shuzhen Wang, and Aimin Tan, and Junfang Lv, and Peng Wang, and Xiaojin Yin, and Yijun Chen
July 2016, Applied microbiology and biotechnology,
Shuzhen Wang, and Aimin Tan, and Junfang Lv, and Peng Wang, and Xiaojin Yin, and Yijun Chen
January 2018, Avicenna journal of medical biotechnology,
Shuzhen Wang, and Aimin Tan, and Junfang Lv, and Peng Wang, and Xiaojin Yin, and Yijun Chen
October 2017, Protein expression and purification,
Shuzhen Wang, and Aimin Tan, and Junfang Lv, and Peng Wang, and Xiaojin Yin, and Yijun Chen
May 2020, Protein expression and purification,
Shuzhen Wang, and Aimin Tan, and Junfang Lv, and Peng Wang, and Xiaojin Yin, and Yijun Chen
September 2015, Protein expression and purification,
Shuzhen Wang, and Aimin Tan, and Junfang Lv, and Peng Wang, and Xiaojin Yin, and Yijun Chen
March 2008, Clinical and experimental medicine,
Shuzhen Wang, and Aimin Tan, and Junfang Lv, and Peng Wang, and Xiaojin Yin, and Yijun Chen
June 2005, Protein expression and purification,
Shuzhen Wang, and Aimin Tan, and Junfang Lv, and Peng Wang, and Xiaojin Yin, and Yijun Chen
April 2021, Sheng wu gong cheng xue bao = Chinese journal of biotechnology,
Shuzhen Wang, and Aimin Tan, and Junfang Lv, and Peng Wang, and Xiaojin Yin, and Yijun Chen
January 2022, Advanced biomedical research,
Shuzhen Wang, and Aimin Tan, and Junfang Lv, and Peng Wang, and Xiaojin Yin, and Yijun Chen
May 2005, Sheng wu gong cheng xue bao = Chinese journal of biotechnology,
Copied contents to your clipboard!